A self-designed CpG ODN enhanced the anti-melanoma effect of pimozide

Huijie Jia1, Jing Guo2, Pingping Wang3

  • 1Institute of Precision Medicine, Xinxiang Medical University, 601 Jinsui Road, Xinxiang 453007, China; Xinxiang Key Laboratory of Tumor Vaccine and Immunotherapy, Xinxiang Medical University, Xinxiang, China; Department of Pathology, Xinxiang Medical University, Xinxiang, China.

Insights

This study shows that combining pimozide with CpG oligodeoxynucleotides (CpG ODN) effectively inhibits melanoma growth and enhances anti-tumor immunity in mice. This combination therapy offers a promising strategy for improving melanoma treatment outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Melanoma is an aggressive skin cancer requiring novel therapeutic strategies.
  • Pimozide demonstrates melanoma growth inhibition, but its efficacy needs enhancement.
  • Tumor immunotherapy, particularly using Toll-like receptor 9 (TLR9) agonists like CpG ODN, shows promise in cancer eradication.

Purpose of the Study:

  • To investigate the combined therapeutic effects of pimozide and CpG ODN in a melanoma mouse model.
  • To evaluate the impact of this combination therapy on tumor growth, survival, and immune cell profiles.

Main Methods:

  • Melanoma-bearing mice were treated with pimozide alone, CpG ODN alone, or a combination of both.
  • Tumor growth, survival rates, and immune cell infiltration (CD4+, CD8+ T cells, NK cells) were assessed.
  • Expression levels of MMP2 and p-Stat5 were analyzed.

Main Results:

  • The combination of pimozide and CpG ODN significantly inhibited melanoma tumor growth and prolonged mouse survival.
  • Combined treatment suppressed MMP2 and p-Stat5 expression.
  • Increased infiltration and ratios of CD4+, CD8+ T cells, and NK cells were observed in tumors.

Conclusions:

  • Pimozide combined with CpG ODN demonstrates enhanced anti-melanoma efficacy compared to monotherapy.
  • The combination therapy may exert its effects through inducing apoptosis, inhibiting invasion, and modulating the immune response.
  • Further research into optimized combination therapies involving pimozide is warranted.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
733
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K